ProBiotix Health Plc (AQU:PBX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
8.00
+0.38 (4.92%)
At close: Apr 27, 2026
10.34%
Market Cap 12.65M
Revenue (ttm) 2.73M
Net Income (ttm) -1.23M
Shares Out 158.17M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open n/a
Previous Close 7.63
Day's Range n/a
52-Week Range 5.75 - 10.00
Beta -0.01
RSI 54.25
Earnings Date Mar 30, 2026

About ProBiotix Health

ProBiotix Health Plc develops probiotics to tackle cardiovascular disease and other lifestyle conditions in the United Kingdom, the United States, and internationally. It offers various products, including YourBiotixMH for menopause health; YourBiotixPMH for post-menopause health; YourBiotixCH for cholesterol maintenance; YourBiotixCH InstaMelt for cholesterol health; YourBiotixBP for blood pressure reduction; and YourBiotixVH for vascular health support. The company was formerly known as ProBiotix Health Limited and changed its name to ProBiot... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2012
Employees 12
Stock Exchange Aquis Exchange
Ticker Symbol PBX
Full Company Profile

Financial Performance

In 2025, ProBiotix Health's revenue was 2.73 million, an increase of 45.09% compared to the previous year's 1.88 million. Losses were -1.23 million, 45.6% more than in 2024.

Financial Statements

News

There is no news available yet.